| Nov 14 |
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
|
| Nov 11 |
ACHV: Commercialization in Focus
|
| Oct 24 |
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
|
| Oct 23 |
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting
|
| Oct 16 |
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
|
| Oct 10 |
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
|
| Oct 1 |
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
|
| Sep 4 |
ACHV: New Skipper at the Helm
|
| Aug 19 |
ACHV: ORCA OL Enrolling at Rapid Pace
|
| Aug 14 |
Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript
|
